ArticleFood science & nutrition2025
Effect of Cold Plasma on the Microbial Safety and Physicochemical Properties of Functional Supplement Powder.
Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effect of Cold Plasma on the Microbial Safety and Physicochemical Properties of Functional Supplement Powder.Food science & nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cold plasma (CP) was used as an innovative nonthermal approach for the decontamination of a functional supplement powder containing fish oil, hydrolyzed fish protein, and shrimp lipid extract in a liposomal structure-a lipid-rich food matrix with high sensitivity to marine bioactive compound degradation. The supplement powder underwent CP treatment (air atmospheric) for 10-20 min at 8-12 kV, and its safety and physicochemical properties were investigated. Optimal conditions (20 min, 12 kV) resulted in a significant reduction in psychrotrophic bacteria, mesophilic bacteria, and mold and yeast by 2.88, 2.67, and 0.35 log CFU/g, respectively (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.